blood clots

Impatience and a lack of clarity persisted Thursday over the fate of thousands of doses of the Oxford-AstraZeneca vaccine set to expire in the coming weeks.

Several family doctors and physician associations across Canada say they welcome questions from anyone concerned about second doses of Oxford-AstraZeneca or any other COVID-19 vaccine.

The U.S. Centers for Disease Control and Prevention says people fully vaccinated against COVID-19 no longer need to wear masks outdoors and in most indoor settings, but one of Canada's top public health officials suggests a different approach would be taken here.

Canadian provinces suspended use of the Oxford-AstraZeneca COVID-19 vaccine in people under age 55 on Monday, March 29, 2021, acting on an advisory committee's concerns about a possible link between the shot and rare blood clots.

The federal government is expecting around 1.5 million doses of the Oxford-AstraZeneca vaccine from the United States today, March 30, 2021.

Canada's procurement minister says a deal is close to receive Oxford-AstraZeneca vaccine doses from the U.S., while the military commander in charge of the rollout here says all adults who wish could be able to get their first shot by July 1.

The National Advisory Committee on Immunization adjusted on Tuesday, March 16, 2021, its advice for the use of the Oxford-AstraZeneca vaccine to say that it can now be given to seniors.

The National Advisory Committee on Immunization says there is now enough "real-world evidence" to show the Oxford-AstraZeneca COVID-19 vaccine is both safe and effective for seniors.

Prime Minister Justin Trudeau offered reassurances on the safety of the Oxford-AstraZeneca COVID-19 vaccine on Monday, March 15, 2021, as the list of European countries suspending its use due to safety concerns grew.